The recent drug price negotiation shocked everyone after short-acting insulin was added to the list of drugs for negotiation.
The Biden administration shocked everyone after adding short-acting insulin to the list up for negotiations. (Photo: Everyday Health)
Shocking Drug Price Negotiation
It is said to be a victory after news about the drug price negotiation was recently announced. Insulin prices have gone up over the years it being added to the list for drug price negotiations is a win, especially for those people who rely on it.
The Biden administration shocked everyone after the news about the drug price negotiation. Short-acting insulin is now added to the list of drugs that would be subjected to drug price negotiations.
Medicare will be the one to do the drug price negotiations and is expected to have a good outcome. This good news about the drug price negotiations is said to show and prove that the Biden administration is not playing around when it comes to healthcare.
According to a published article by The Intercept, insulin is a very unexpected drug to be seen under the list for drug price negotiations. This sudden but very pleasant news about the drug price negotiation is said to have caught everyone off guard.
10 Prescription Medicines Up For Negotiation
In a published article by Reuters, there is a total of 10 prescription drugs on the list for negotiation to have their prices lower. The Inflation Reduction Act that was signed last year allowed Medicare to be able to conduct these types of negotiations.
